Kabra Drugs informs about disclosure

19 Sep 2024 Evaluate
Kabra Drugs has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kuniamuthur Nanjappan Anand.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

27.00 0.02 (0.07%)
22-Jan-2026 15:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1633.55
Dr. Reddys Lab 1215.50
Cipla 1369.45
Zydus Lifesciences 885.15
Lupin 2164.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×